These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 15372592)
1. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat. González-Hernández T; Barroso-Chinea P; Rodríguez M Mov Disord; 2004 Sep; 19(9):1029-1042. PubMed ID: 15372592 [TBL] [Abstract][Full Text] [Related]
2. Colocalization of tyrosine hydroxylase and GAD65 mRNA in mesostriatal neurons. González-Hernández T; Barroso-Chinea P; Acevedo A; Salido E; Rodríguez M Eur J Neurosci; 2001 Jan; 13(1):57-67. PubMed ID: 11135004 [TBL] [Abstract][Full Text] [Related]
3. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression. Sedaghat K; Finkelstein DI; Gundlach AL Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193 [TBL] [Abstract][Full Text] [Related]
4. Distribution of GABAergic neurons in the striatum of amygdala-kindled rats: an immunohistochemical and in situ hybridization study. Löscher W; Schirmer M; Freichel C; Gernert M Brain Res; 2006 Apr; 1083(1):50-60. PubMed ID: 16545783 [TBL] [Abstract][Full Text] [Related]
5. Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat. Soghomonian JJ; Chesselet MF Synapse; 1992 Jun; 11(2):124-33. PubMed ID: 1626311 [TBL] [Abstract][Full Text] [Related]
6. GABAergic control of substantia nigra dopaminergic neurons. Tepper JM; Lee CR Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115 [TBL] [Abstract][Full Text] [Related]
7. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway. Enna SJ; Reisman SA; Stanford JA Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350 [TBL] [Abstract][Full Text] [Related]
8. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis. Lavoute C; Weiss M; Rostain JC Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916 [TBL] [Abstract][Full Text] [Related]
9. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production. Sajadi A; Bauer M; Thöny B; Aebischer P J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064 [TBL] [Abstract][Full Text] [Related]
10. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells. Isacson O; Bjorklund LM; Schumacher JM Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105 [TBL] [Abstract][Full Text] [Related]
11. Rapid increase of Nurr1 expression in the substantia nigra after 6-hydroxydopamine lesion in the striatum of the rat. Ojeda V; Fuentealba JA; Galleguillos D; Andrés ME J Neurosci Res; 2003 Sep; 73(5):686-97. PubMed ID: 12929136 [TBL] [Abstract][Full Text] [Related]
12. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease. Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343 [TBL] [Abstract][Full Text] [Related]
13. Neuronal firing activity and gene expression changes in the subthalamic nucleus after transplantation of dopamine neurons in hemiparkinsonian rats. Rumpel R; Alam M; Klein A; Özer M; Wesemann M; Jin X; Krauss JK; Schwabe K; Ratzka A; Grothe C Neurobiol Dis; 2013 Nov; 59():230-43. PubMed ID: 23938762 [TBL] [Abstract][Full Text] [Related]
14. Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies. Xu L; Sheng J; Tang Z; Wu X; Yu Y; Guo H; Shen Y; Zhou C; Paraoan L; Zhou J Neurobiol Dis; 2005 Feb; 18(1):152-65. PubMed ID: 15649706 [TBL] [Abstract][Full Text] [Related]
15. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level. Lavoute C; Weiss M; Rostain JC Brain Res; 2007 Oct; 1176():37-44. PubMed ID: 17900538 [TBL] [Abstract][Full Text] [Related]
16. Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: effects of subthalamotomy and levodopa treatment. Bilbao G; Ruiz-Ortega JA; Miguens N; Ulibarri I; Linazasoro G; Gómez-Urquijo S; Garibi J; Ugedo L Brain Res; 2006 Apr; 1084(1):175-84. PubMed ID: 16574080 [TBL] [Abstract][Full Text] [Related]
17. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion. Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980 [TBL] [Abstract][Full Text] [Related]
18. Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine. Iwata SI; Nomoto M; Fukuda T Synapse; 2001 Jan; 39(1):16-22. PubMed ID: 11071705 [TBL] [Abstract][Full Text] [Related]
19. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease. Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433 [TBL] [Abstract][Full Text] [Related]
20. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat. Wang S; Zhang QJ; Liu J; Wu ZH; Wang T; Gui ZH; Chen L; Wang Y Neuroscience; 2009 Mar; 159(2):850-61. PubMed ID: 19174182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]